Status:
NOT_YET_RECRUITING
Long-term Prognosis of Patients With Sepsis After Immunotherapy
Lead Sponsor:
Sun Yat-sen University
Conditions:
Long-term Effects of Thymosin Alpha 1 Treatment
Eligibility:
All Genders
Brief Summary
Current clinical studies of thymosin α1 for sepsis have focused on short-term outcomes (28-day or 90-day mortality), and lack of clinical data on long-term outcomes (3 year mortality) of patients with...
Eligibility Criteria
Inclusion
- Sepsis patients in the TESTS study Patients who discharged from hospital after recovery
Exclusion
- None
Key Trial Info
Start Date :
July 1 2021
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
March 31 2027
Estimated Enrollment :
900 Patients enrolled
Trial Details
Trial ID
NCT04901104
Start Date
July 1 2021
End Date
March 31 2027
Last Update
May 25 2021
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.